• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BC R 1X40 US; BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BC R 1X40 US; BONE CEMENT Back to Search Results
Catalog Number 110034355
Device Problems Biocompatibility (2886); Patient Device Interaction Problem (4001)
Patient Problems Hypersensitivity/Allergic reaction (1907); Pain (1994); Rash (2033); Swelling/ Edema (4577)
Event Type  Injury  
Event Description
It was reported that the patient underwent diagnostic intervention (biopsy for metal allergy) greater than six months from initial surgery.The patient also experiences pain and swelling.Due diligence is in progress for this event; to date no further information has been provided.
 
Manufacturer Narrative
(b)(4).Medical devices: oxf anat brg lt md size 4 pma; item# 159548; lot# unknown.Oxf twin-peg cmntd fem md pma; item# 161469; lot# unknown.Oxf uni tib tray sz d lm pma; item# 154724; lot# unknown.The device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Event Description
No further event information available at the time of this report.
 
Manufacturer Narrative
(b)(4).Product was not returned or pictures not provided.Visual device evaluation could not be performed.The dhr review can¿t be performed as the item/batch number was not provided.This device is used for treatment.Medical records were not provided.A definitive root cause cannot be determined as the result of the biopsy regarding allergic reaction was not provided.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BC R 1X40 US
Type of Device
BONE CEMENT
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key16172718
MDR Text Key307471732
Report Number3006946279-2023-00003
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171540
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/16/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number110034355
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Treatment
SEE H10 NARRATIVE
Patient Outcome(s) Other;
Patient SexMale
-
-